Search Results - "Larsen, SO"

Relation of 97T Polymorphism in KCNE5 to Risk of Atrial Fibrillation by Ravn, Lasse S., Hofman-Bang, Jacob, Dixen, Ulrik, Larsen, Severin Olesen, Jensen, Gorm, Haunsø, Stig, Svendsen, Jesper Hastrup, Christiansen, Michael

“…The 97T polymorphism of the KCNE5 gene, coding for an inhibitory β-subunit, MiRP4, of the repolarizing cardiac potassium ion channel KCNQ1, was significantly…”
Get full text

Increased risk of preterm delivery and pre‐eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia by Naver, KV, Grinsted, J, Larsen, SO, Hedley, PL, Jørgensen, FS, Christiansen, M, Nilas, L

“…Objective To study the risk of adverse pregnancy outcomes in women with polycystic ovary syndrome (PCOS), and to examine the role of hyperandrogenaemia. Design…”
Get full text

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia by PEDERSEN-BJERGAARD, J, PHILIP, P, LARSEN, S. O, JENSEN, G, BYRSTING, K

“…Cytogenetic studies of 91 consecutive patients with therapy-related myelodysplasia or overt acute nonlymphocytic leukemia disclosed characteristic defects of…”
Get full text

Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment by Lebech, Morten, Andersen, Ole, Christensen, Niels Christian, Hertel, Jens, Nielsen, Hans Erik, Peitersen, Birgit, Rechnitzer, Catherine, Larsen, Severin Olesen, Nørgaard-Pedersen, Bent, Petersen, Eskild

“…The best method for prevention and control of congenital toxoplasma infection is uncertain. Prenatal screening is done in Austria and France, but the effect of…”
Get full text

Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk women by Wøjdemann, K. R., Shalmi, A. C., Christiansen, M., Larsen, S. O., Sundberg, K., Brocks, V., Bang, J., Nørgaard‐Pedersen, B., Tabor, A.

“…Objective To determine the performance of screening for Down syndrome (DS) and other major chromosomal abnormalities using nuchal translucency (NT), free…”
Get full text

An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing by Christiansen, Michael, Olesen Larsen, Severin

“…We assessed the discriminatory efficiency and cost‐effectiveness of a novel way of organising first trimester screening for Down syndrome (DS), contingent…”
Get full text

Quality assessment in prospective nuchal translucency screening for Down syndrome by Wøjdemann, K. R., Christiansen, M., Sundberg, K., Larsen, S. O., Shalmi, A., Tabor, A.

“…Objectives To develop and apply a quality control system in a Down syndrome screening study using nuchal translucency as an interventional marker. Methods In a…”
Get full text

Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs by Wøjdemann, Karen R., Larsen, Severin Olesen, Shalmi, Anne-Cathrine, Sundberg, Karin, Tabor, Ann, Christiansen, Michael

“…Objectives To establish the distribution of serological and ultrasound first‐trimester Down syndrome markers in twins and identify correlations of significance…”
Get full text

Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements by Andersen, MK, Johansson, B, Larsen, SO, Pedersen-Bjergaard, J

“…Finsen Center, Rigshospitalet-University Hospital, Department of Medical Statistics, Copenhagen, Denmark. BACKGROUND AND OBJECTIVE: In therapy-related…”
Get full text

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours by Pedersen-Bjergaard, J, Daugaard, G, Hansen, S W, Philip, P, Larsen, S O, Rørth, M

“…Among the cytostatic drugs only the alkylating agents have been firmly established as being leukaemogenic. This report describes 4 cases of acute myeloid…”
Get more information

First trimester screening for Down syndrome and assisted reproduction: no basis for concern by Wøjdemann, K. R., Larsen, S. O., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

“…In pregnancies obtained after assisted reproduction the false‐positive rate of second trimester Down syndrome (DS) screening is increased by 1.5–3‐fold. This…”
Get full text

Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndrome by Sørensen, Tina, Larsen, Severin Olesen, Christiansen, Michael

“…Objective To assess whether existing weight correction formulas for PAPP‐A and free‐beta‐hCG developed for weeks 11 to 14 can be applied to pregnancies in…”
Get full text

Which contingent sequential screening protocol? by Larsen, Severin Olesen, Christiansen, Michael, Norgaard-Pedersen, Bent

Get full text

Diagnostic assessment of haemorrhagic rash and fever by Nielsen, H E, Andersen, E A, Andersen, J, Böttiger, B, Christiansen, K M, Daugbjerg, P, Larsen, S O, Lind, I, Nir, M, Olofsson, K

“…AIMS To establish criteria for early distinction between meningococcal disease and other conditions with similar clinical features, and to identify other…”
Get full text

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series by Pedersen-Bjergaard, J, Philip, P, Larsen, S O, Andersson, M, Daugaard, G, Ersbøll, J, Hansen, S W, Hou-Jensen, K, Nielsen, D, Sigsgaard, T C

“…Therapy-related acute myeloid leukemia (t-AML), often presenting as myelodysplasia (t-MDS), has become the most serious long-term complication of cancer…”
Get more information

Gender impact on first trimester markers in Down syndrome screening by Larsen, Severin Olesen, Wøjdemann, Karen R., Shalmi, Anne-Cathrine, Sundberg, Karin, Christiansen, Michael, Tabor, Ann

“…The influence of fetal gender on the level in the first trimester of the serological markers alpha‐fetoprotein (AFP), pregnancy‐associated plasma protein‐A…”
Get full text

First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A by Wøjdemann, K. R., Larsen, S. O., Rode, L., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

“…Objective. First trimester screening for fetal chromosomal disease is now possible using the maternal serological markers pregnancy-associated plasma protein-A…”
Get full text

Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening by Christiansen, Michael, Larsen, Severin Olesen, Nørgaard-Pedersen, Bent

Get full text

Precision of risk in multidimensional likelihood ratio based screening with first trimester screening for Down's syndrome as a special case by Christiansen, M, Larsen, S O

“…The development of computer programs for the calculation of risks and Monte Carlo estimation of the precision of such risks in likelihood ratio based screening…”
Get more information

Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers by PETERSEN, E, RØNNE, T, RØNN, A, BYGBJERG, I, LARSEN, S. O

“…The aim of the study was to provide data on the relative frequency of reported symptoms in travelers using chloroquine, chloroquine plus proguanil, and…”
Get full text